BCH declines, for the 17th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Coverage naming BCH
Reporting from across the Journal that names Bachem Holding (Suzhou) Co., Ltd., or that bears directly on the questions its dossier leaves open. The dossier itself — the testing record, the correspondence log and the verification box — is here.
Independent analysis puts a BCH mazdutide lot at 96.0%, against 93.7% on the certificate
A reminder that a purity figure is the output of a method, and that methods differ.
Independent analysis puts a BCH orforglipron lot at 97.2%, against 93.1% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
BCH declines, for the 14th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
BCH declines, for the 22nd time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
BCH declines, for the 10th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at BCH in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at BCH in February, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a BCH mazdutide lot at 95.5%, against 94.0% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
What changed at BCH in September, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a BCH mazdutide lot at 98.6%, against 96.0% on the certificate
The supplier has not disputed the finding. It has not explained the gap either.
What changed at BCH in August, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
BCH declines, for the 6th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a BCH cagrilintide lot at 96.1%, against 95.2% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
BCH declines, for the 7th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a BCH tirzepatide lot at 98.3%, against 94.9% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Independent analysis puts a BCH cagrilintide lot at 96.6%, against 93.4% on the certificate
The result is unremarkable. What the report omits is not.
Independent analysis puts a BCH semaglutide lot at 95.2%, against 91.2% on the certificate
The supplier has not disputed the finding. It has not explained the gap either.